Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.

Autor: Palanques-Pastor T; Pharmacy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Megías-Vericat JE; Pharmacy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Martínez P; Hematology and Hemotherapy Department, Hospital Universitario, Madrid, Spain., López Lorenzo JL; Hematology and Hemotherapy Department, Hospital Universitario Fundación Jiménez Díaz, Valencia, Spain., Cornago Navascués J; Hematology and Hemotherapy Department, Hospital Universitario Fundación Jiménez Díaz, Valencia, Spain., Rodriguez Macias G; Hematology and Hemotherapy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Cano I; Hematology and Hemotherapy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Arnan Sangerman M; Clinic Hematology Department, Instituto Catalán de Oncología, Hospitalet de Llobregat, Spain., Vidriales Vicente MB; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Algarra Algarra JL; Hematology Department, Hospital General Universitario de Albacete, Albacete, Spain., Foncillas MÁ; Hematology and Hemotherapy Department, Hospital Universitario Infanta Leonor, Madrid, Spain., Herrera P; Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Botella Prieto C; Hematology and Hemotherapy Department, Hospital General Universitario de Alicante, Alicante, Spain., Vives S; Clinic Hematology Department, Instituto Catalán de Oncología, Badalona, Spain., Figuera Álvarez Á; Hematology and Hemotherapy Department, Hospital Universitario de La Princesa, Madrid, Spain., Cuevas Palomares L; Hematology and Hemotherapy Department, Hospital Txagorritxu, Vitoria-Gasteiz, Spain., Sobas M; Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wrocław, Poland., Contento Gonzalo A; Hematology and Hemotherapy Department, Hospital Regional Universitario de Málaga, Málaga, Spain., Cuello García R; Hematology and Hemotherapy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Amutio Diez ME; Hematology and Hemotherapy Department, Hospital Universitario Cruces, Barakaldo, Spain., De Miguel Llorente D; Hematology Department, Hospital Universitario de Guadalajara, Guadalajara, Spain., Navas Elorza B; Hematology and Hemotherapy Department, Hospital HLA Universitario Moncloa, Madrid, Spain., Bergua Burgues JM; Hematology and Hemotherapy Department, Hospital San Pedro de Alcántara, Cáceres, Spain., Bernal Del Castillo T; Hematology and Hemotherapy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Mateos Rodríguez MC; Hematology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., de Cabo López E; Hematology Department, Hospital Universitario del Bierzo, Ponferrada, Spain., Franco Villegas AC; Oncology and Medical Hematology, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain., García Boyero R; Hematology and Hemotherapy Department, Hospital General Universitario de Castellón, Castellón de la Plana, Spain., Escolano Escobar C; Hematology and Hemotherapy Department, Hospital Universitario de Getafe, Getafe, Spain., Seri Merino C; Hematology and Hemotherapy Department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain., Cervero C; Hematology Department, Hospital Virgen de la Luz, Cuenca, Spain., Roldán Pérez A; Hematology and Hemotherapy Department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain., Hermosín Ramos L; Hematology and Hemotherapy Department, Hospital Jerez de la Frontera, Jerez de la Frontera, Spain., Cervera Calvo M; Hematology Department, Hospital Universitario Joan XXIII, Tarragona, Spain., Olave MT; Hematology and Hemotherapy Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Villafuerte Gutiérrez P; Hematology and Hemotherapy Department, Hospital Universitario Príncipe de Asturias, Meco, Spain., de Laiglesiai A; Hematology and Hemotherapy Department, Hospital Universitario Puerta del Hierro, Majadahonda, Spain., Serrano J; Hematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain., Najera Irazu MJ; Hematology Department, Hospital San Pedro, Logroño, Spain., Piñana JL; Hematology and Hemotherapy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Sanz MÁ; Hematology and Hemotherapy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Martínez-López J; Hematology and Hemotherapy Department, Hospital Universitario, Madrid, Spain., Montesinos P; Hematology and Hemotherapy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 2928-2938. Date of Electronic Publication: 2021 Jul 22.

P568: REAL‐LIFE EXPERIENCE OF TREATMENT REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS WITH VENETOCLAX COMBINATION THERAPY.

Autor: Pomares Marin, H., Villarreal Hernández, J., Condom Esteve, M., Vives Polo, S., Cervera Calvo, M., Coll Jorda, R., Maluquer Artigal, C., Ibarra Fernández, G., Torrent Catarineu, A., Galiano Barajas, M., Sureda Balari, A. M., Arnan Sangerman, M.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p467-468, 2p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.